HBRMHerborium Group, Inc.

About Herborium Group, Inc. (HBRM)

Herborium Group, Inc. (HBRM) is a Drug Manufacturers - Specialty & Generic company headquartered in Houston, TX, United States whose shares trade over-the-counter on the Pink tier.

Herborium Group, Inc., is a novel botanical therapeutics' company focused on developing, licensing, and marketing of proprietary, botanical based medicinal products, targeting unmet medical needs. The Company responds to both consumers and healthcare professionals demand for safe, efficacious, all natural medicinal options for treatment and prevention of selected diseases and health concerns.

Products and services

Herborium is a disruptive nutraceutical company, an inventor and marketer of trade secret and patent protected, all- natural medicinal products targeting both consumers and healthcare professionals seeking alternative and complementary answers to disease treatment, man-agement and prevention. Each product is selected based on a strong statement of market needs and supported by customized content. The Company utilizes clinical validation and a proactive approach to regulatory strategy to establish and maintain a differential advantage. To realize these goals, Herborium has developed collaborative relationships with proactive medical institutions in the US, UK, Australia and Singapore The Company employs Health Care Information Technology to empower its customer and consumer base to make informed medical and self-medication decisions. HERBORIUM defines its products as “Bridge Products,” which are botanical therapeutics™ (medicines) with a record of clinical efficacy and safety which can be marketed in the US and Europe as dietary supplements, thereby allowing for immediate market entry. Herborium’s use of pharmaceutical grade QC and QA standards will further enhance its differential advantage. The Company products focus on dermatological needs ( acne and aging) and women and men health

HBRM key facts

Ticker symbol

HBRM

Market tier

Pink

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Headquarters

Houston, TX, United States

Country of incorporation

US

Year of incorporation

2020

Employees

7

Estimated market cap

$546.0K (as of Apr 10, 2025)

Shares outstanding

10,919,428,835

Reporting standard

Alternative Reporting Standard

Audit status

Unaudited

Fiscal year end

11/30

Latest filing

Annual Report (Nov 30, 2024)

Herborium Group, Inc. leadership

• Agnes P Olszewski — CEO, President, Founder

Explore more: Drug Manufacturers - Specialty & Generic stocks · Healthcare sector · Pink stocks · OTC stocks starting with H